Brain endothelial and neural cell membranes

Brain endothelial and neural cell membranes refer to the lipid bilayers and associated structural components of the cells forming the blood-brain barrier (BBB) and the functional units of the central nervous system, including neurons and glia [StatPearls, 2023]. These membranes are not a single molecular target but rather a complex physiological site involved in maintaining the specialized microenvironment of the brain and regulating the passage of substances [NCBI, 2022]. Historically, these membranes were considered the primary site of action for general anesthetics via the Meyer-Overton hypothesis, which suggested that anesthetic potency correlated with lipid solubility within the neuronal membrane [PubMed, 2001]. In modern pharmacology, while specific proteins like ion channels are recognized as the primary targets for most drugs, the physical properties and integrity of these membranes remain critical for drug delivery and the action of osmotic agents [PubChem, 2024]. For example, mannitol acts on endothelial cell membranes to induce osmotic shrinkage, thereby opening tight junctions to facilitate drug transport or reduce intracranial pressure [NIH, 2023]. Disruption of these membranes is a hallmark of various pathological states, including stroke and traumatic brain injury, where barrier failure leads to vasogenic edema [NCBI, 2022]. Consequently, therapeutic strategies often focus on either preserving membrane integrity or temporarily modulating it to enhance the delivery of neuroprotective agents.

Other names

Blood-brain barrier membranesNeuronal membranesEndothelial membranesCNS cell membranesCerebrovascular endothelial membranes

Drugs targeting these membranes typically act through non-specific physical interactions or osmotic gradients. Osmotic agents like mannitol create a concentration gradient across the endothelial cell membrane, leading to cell shrinkage and the transient opening of tight junctions [StatPearls, 2023]. General anesthetics were historically thought to dissolve into the lipid bilayer of neural membranes, altering membrane fluidity and indirectly affecting the function of embedded proteins [PubMed, 2001]. Contrast agents like gadobutrol are used to assess the integrity of these membranes by monitoring their passage across the BBB [NIH, 2023].